Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
9
Number of overlapping holdings
39.1%
% of PPH's 26 holdings also in PJP
31.0%
% of PJP's 29 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.3% | 5.2% | 5.2% |
|
ABBVIE INC | 6.2% | 5.0% | 5.0% |
|
JOHNSON & JOHNSON | 6.4% | 4.9% | 4.9% |
|
MERCK & CO. INC. | 4.3% | 5.0% | 4.3% |
|
PFIZER INC | 4.2% | 4.8% | 4.2% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to PJP
|
ELI LILLY & CO | 6.2% |
 |
NOVARTIS AG-ADR | 5.6% |
|
CENCORA INC | 5.3% |
|
MCKESSON CORP | 5.1% |
 |
NOVO-NORDISK A/S-SPONS ADR | 5.1% |
 |
TEVA PHARMACEUTICAL-SP ADR | 5.0% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.0% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.9% |
|
ZOETIS INC | 4.9% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.6% |
PPH Underweight Relative to PJP
|
AMGEN INC | -5.1% |
|
GILEAD SCIENCES INC | -5.0% |
|
ABBOTT LABORATORIES | -4.9% |
|
OCULAR THERAPEUTIX INC | -3.5% |
|
INNOVIVA, INC. | -3.0% |
|
BIOSANTE PHARMACEUTICALS INC | -2.8% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -2.8% |
|
TARSUS PHARMACEUTICALS, INC. | -2.8% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.8% |
|
LIGAND PHARMACEUTICALS-CL B | -2.8% |